74 results
6-K
EX-99.1
LEGN
Legend Biotech Corp
22 Apr 24
Current report (foreign)
1:06pm
) cell-based immunotherapy. From our three R&D sites around the world, we apply these innovative technologies to pursue the discovery of cutting-edge
6-K
EX-99.1
LEGN
Legend Biotech Corp
8 Apr 24
Current report (foreign)
7:03am
cell (gd T) and natural killer (NK) cell-based immunotherapy. From our three R&D sites around the world, we apply these innovative technologies
6-K
EX-99.1
LEGN
Legend Biotech Corp
15 Mar 24
FDA ODAC votes 11 to 0 supporting favorable risk-benefit assessment of CARVYKTI based on results from the Phase 3 CARITUDE-4 study
3:18pm
chimeric antigen receptor T-cell, gamma-delta T cell (gd T) and natural killer (NK) cell-based immunotherapy. From our three R&D sites around the world
6-K
EX-99.1
LEGN
Legend Biotech Corp
11 Mar 24
Legend Biotech Reports Fourth Quarter and Full Year 2023 Results and Recent Highlights
7:52am
killer (NK) cell-based immunotherapy. From our three R&D sites around the world, we apply these innovative technologies to pursue the discovery
6-K
EX-99.1
LEGN
Legend Biotech Corp
23 Feb 24
Current report (foreign)
7:16am
-cell, gamma-delta T cell (gd T) and natural killer (NK) cell-based immunotherapy. From our three R&D sites around the world, we apply
6-K
EX-99.1
zhqz6
9 Jan 24
Legend Biotech Corporation 6-K
4:01pm
6-K
EX-99.1
eba1 js72ipl2u
11 Dec 23
Legend Biotech Corporation 6-K
7:32pm
6-K
EX-99.1
0yv ywwjzhlze8qnd
20 Nov 23
Legend Biotech Reports Third Quarter 2023 Results and Recent Highlights
6:02am
6-K
EX-99.1
7y68d20
13 Nov 23
Legend Biotech Corp. 6-K
8:30am
6-K
EX-99.1
3oau5vk
15 Aug 23
Legend Biotech Reports Second Quarter 2023 Results and Recent Highlights
6:10am
6-K
EX-99.1
t38gc9uz9nm88
6 Jun 23
Legend Biotech Corporation 6-K
4:44pm
6-K
EX-99.1
0ummxj
5 Jun 23
Legend Biotech 6-K
11:17am
6-K
EX-99.1
x388aas6b2qsnhvia tc
25 May 23
Legend Biotech Corporation 6-K
8:30am
6-K
EX-99.1
yexb2
18 May 23
Legend Biotech Corporation 6-K
8:30am
6-K
EX-99.1
v7ee33bndo2talba19js
16 May 23
Legend Biotech Corporation 6-K
8:39am
6-K
EX-99.1
wtwiqp khyze1x6r8em
8 May 23
Announces Pricing of Registered Direct Offering of US$350 million of American Depositary Shares
8:46am
6-K
EX-99.1
1p1sgn1grhg
3 Apr 23
Legend Biotech 6-K
4:01pm
6-K
EX-99.1
vanz41m
30 Mar 23
Legend Biotech Corporation 6-K
4:01pm
6-K
EX-99.1
9z53 o0ah2tit7d9
21 Nov 22
Legend Biotech Corp. 6-K
8:30am
6-K
EX-99.1
txy7kvmp2hbq
4 Nov 22
Legend Biotech Corporation 6-K
5:01pm